Involvement of the serotoninergic system in the mechanism of action of ultralow dose antibodies to S-100 protein

Bulletin of Experimental Biology and Medicine

Volumn 143, Issue 5, 2007, Pages 598-600

  Kheifets, I A ^a   Dugina, Yu L ^a   Voronina, T A ^a   Molodavkin, G M ^a   Martyushev Poklad, A V ^a   Sergeeva, S A ^a   Epstein, O I ^a  

^a Materia Medica Holding R   (Russian Federation)

Author keywords

Anxiety; Depression; Serotoninergic system; Ultralow dose antibodies to S 100 protein

Indexed keywords

5 HYDROXYTRYPTOPHAN; AMITRIPTYLINE; DIAZEPAM; KETANSERIN; PROTEIN ANTIBODY; PROTEIN S 100; PROTEIN S 100 ANTIBODY; SEROTONIN AGONIST; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; LOW DRUG DOSE; MALE; NONHUMAN; RAT; SEROTONINERGIC SYSTEM; TRANQUILIZING ACTIVITY;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; KETANSERIN; MALE; RATS; S100 PROTEINS; SEROTONIN; SEROTONIN ANTAGONISTS;

EID: 34948853807     PISSN: 00074888     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10517-007-0191-y     Document Type: Article

References (10)

1. T. A. Voronina, O. I. Epstein, G. M. Molodavkin, et al., Radioekologiya, 43, No. 3, 291-293 (2003).
2. G. M. Molodavkin and T. A. Voronina, Eksp. Klin. Farmakol., 58, No. 2, 54-56 (1995).
3. S. N. Mosolov, Psikhiatr. Psikhofarmakoter., 4, No. 1, 140-145 (2002).
4. Manual of Experimental (Preclinical) Studies of New Drugs [in Russian], Ed. V. P. Fisenko, Moscow (2000).
5. P. L. Delgado, D. S. Charney, L. H. Price, et al., Arch. Gen. Psychiatry, 47, No. 5, 411-418 (1990).
6. J. A. Gordon and R. Hen, Neuromolecular Med., 5, No. 1, 27-40 (2004).
7. D. N. Middlemiss, G. W. Price, and J. M. Watson, Curr. Opin. Pharmacol., 2, No. 1, 18-22 (2002).
8. R. D. Porsolt, G. Anton, N. Blavet, and M. Jalfre, Eur. J. Pharmacol., 47, No. 4, 379-391 (1978).
9. J. Vogel, B. Beer, and D. E. Clody, Psychopharmacologia, 21, No. 1, 1-7 (1971).
10. M. D. Wood, C. Reavill, B. Trail, et al., Neuropharmacology, 41, No. 2, 186-199 (2001).